Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up. (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s178. https://doi.org/10.25251/skin.7.supp.178